AleAnna, Inc. (ANNA)

NASDAQ: ANNA · Real-Time Price · USD
7.19
+1.04 (16.91%)
At close: Dec 20, 2024, 4:00 PM
7.38
+0.19 (2.64%)
After-hours: Dec 20, 2024, 7:56 PM EST
16.91%
Market Cap 478.53M
Revenue (ttm) 648,328
Net Income (ttm) -162.45M
Shares Out 66.55M
EPS (ttm) -609.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 28,771
Open 6.00
Previous Close 6.15
Day's Range 6.00 - 8.10
52-Week Range 5.82 - 18.70
Beta 0.03
Analysts n/a
Price Target n/a
Earnings Date n/a

About ANNA

AleAnna Energy, LLC engages in oil and gas exploration and production. The company is based in Houston, Texas. As of November 8, 2010, AleAnna Energy, LLC operates as a subsidiary of Bluescape Resources Company LLC. [Read more]

Founded 2007
Country United States
Stock Exchange NASDAQ
Ticker Symbol ANNA
Full Company Profile

News

AleAnna Announces Signing of Gas Sale Contract with Shell Energy Europe

AleAnna Secures A Contract To Sell Its Gas To Shell Energy Europe Ltd, A Leading Natural Gas, Power And Environmental Trading Company Across European Markets AleAnna has signed a multi-year gas sales ...

2 days ago - GlobeNewsWire

AleAnna, Inc. Announces Completion of Several Major Milestones for its Renewable Natural Gas (RNG) Business

DALLAS and ROME, Dec. 18, 2024 (GLOBE NEWSWIRE) -- AleAnna, Inc., (“AleAnna” or the “Company”) (Nasdaq: ANNA), today announced the completion of a series of initiatives through which the Company has e...

3 days ago - GlobeNewsWire

BRS Resources Announces Update on AleAnna Energy, LLC

Vancouver, British Columbia--(Newsfile Corp. - December 16, 2024) - BRS RESOURCES LTD. (CSE: BRS) (the "Company" or "BRS"), a mineral exploration company, is pleased to provide an update on its member...

4 days ago - Newsfile Corp

HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.

NEW YORK & VERO BEACH, Fla.--(BUSINESS WIRE)---- $ipo #Consumer--HDL Therapeutics, Inc. (“HDL Therapeutics”), a privately held commercial stage biotech company with an FDA-approved cardiovascular ther...

1 year ago - Business Wire

HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment

NEW YORK & VERO BEACH, Fla.--(BUSINESS WIRE)---- $health #Consumer--NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special pu...

1 year ago - Business Wire